These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 27372070)
1. Recurrent and pathological gene fusions in breast cancer: current advances in genomic discovery and clinical implications. Veeraraghavan J; Ma J; Hu Y; Wang XS Breast Cancer Res Treat; 2016 Jul; 158(2):219-32. PubMed ID: 27372070 [TBL] [Abstract][Full Text] [Related]
2. Genomic hotspots but few recurrent fusion genes in breast cancer. Fimereli D; Fumagalli D; Brown D; Gacquer D; Rothé F; Salgado R; Larsimont D; Sotiriou C; Detours V Genes Chromosomes Cancer; 2018 Jul; 57(7):331-338. PubMed ID: 29436103 [TBL] [Abstract][Full Text] [Related]
3. Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer. Hartmaier RJ; Trabucco SE; Priedigkeit N; Chung JH; Parachoniak CA; Vanden Borre P; Morley S; Rosenzweig M; Gay LM; Goldberg ME; Suh J; Ali SM; Ross J; Leyland-Jones B; Young B; Williams C; Park B; Tsai M; Haley B; Peguero J; Callahan RD; Sachelarie I; Cho J; Atkinson JM; Bahreini A; Nagle AM; Puhalla SL; Watters RJ; Erdogan-Yildirim Z; Cao L; Oesterreich S; Mathew A; Lucas PC; Davidson NE; Brufsky AM; Frampton GM; Stephens PJ; Chmielecki J; Lee AV Ann Oncol; 2018 Apr; 29(4):872-880. PubMed ID: 29360925 [TBL] [Abstract][Full Text] [Related]
4. Fusion-associated carcinomas of the breast: Diagnostic, prognostic, and therapeutic significance. Loo SK; Yates ME; Yang S; Oesterreich S; Lee AV; Wang XS Genes Chromosomes Cancer; 2022 May; 61(5):261-273. PubMed ID: 35106856 [TBL] [Abstract][Full Text] [Related]
5. Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines. Ha KC; Lalonde E; Li L; Cavallone L; Natrajan R; Lambros MB; Mitsopoulos C; Hakas J; Kozarewa I; Fenwick K; Lord CJ; Ashworth A; Vincent-Salomon A; Basik M; Reis-Filho JS; Majewski J; Foulkes WD BMC Med Genomics; 2011 Oct; 4():75. PubMed ID: 22032724 [TBL] [Abstract][Full Text] [Related]
6. Fusion Genes in Breast Cancer. Kim J; Han W Adv Exp Med Biol; 2021; 1187():147-157. PubMed ID: 33983577 [TBL] [Abstract][Full Text] [Related]
7. INTEGRATE: gene fusion discovery using whole genome and transcriptome data. Zhang J; White NM; Schmidt HK; Fulton RS; Tomlinson C; Warren WC; Wilson RK; Maher CA Genome Res; 2016 Jan; 26(1):108-18. PubMed ID: 26556708 [TBL] [Abstract][Full Text] [Related]
8. RWCFusion: identifying phenotype-specific cancer driver gene fusions based on fusion pair random walk scoring method. Zhao J; Li X; Yao Q; Li M; Zhang J; Ai B; Liu W; Wang Q; Feng C; Liu Y; Bai X; Song C; Li S; Li E; Xu L; Li C Oncotarget; 2016 Sep; 7(38):61054-61068. PubMed ID: 27506935 [TBL] [Abstract][Full Text] [Related]
9. Gene fusions associated with recurrent amplicons represent a class of passenger aberrations in breast cancer. Kalyana-Sundaram S; Shankar S; Deroo S; Iyer MK; Palanisamy N; Chinnaiyan AM; Kumar-Sinha C Neoplasia; 2012 Aug; 14(8):702-8. PubMed ID: 22952423 [TBL] [Abstract][Full Text] [Related]
10. Oncofuse: a computational framework for the prediction of the oncogenic potential of gene fusions. Shugay M; Ortiz de Mendíbil I; Vizmanos JL; Novo FJ Bioinformatics; 2013 Oct; 29(20):2539-46. PubMed ID: 23956304 [TBL] [Abstract][Full Text] [Related]
11. Recurrent fusion transcripts detected by whole-transcriptome sequencing of 120 primary breast cancer samples. Kim J; Kim S; Ko S; In YH; Moon HG; Ahn SK; Kim MK; Lee M; Hwang JH; Ju YS; Kim JI; Noh DY; Kim S; Park JH; Rhee H; Kim S; Han W Genes Chromosomes Cancer; 2015 Nov; 54(11):681-91. PubMed ID: 26227178 [TBL] [Abstract][Full Text] [Related]
13. Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer. Lei JT; Shao J; Zhang J; Iglesia M; Chan DW; Cao J; Anurag M; Singh P; He X; Kosaka Y; Matsunuma R; Crowder R; Hoog J; Phommaly C; Goncalves R; Ramalho S; Peres RMR; Punturi N; Schmidt C; Bartram A; Jou E; Devarakonda V; Holloway KR; Lai WV; Hampton O; Rogers A; Tobias E; Parikh PA; Davies SR; Li S; Ma CX; Suman VJ; Hunt KK; Watson MA; Hoadley KA; Thompson EA; Chen X; Kavuri SM; Creighton CJ; Maher CA; Perou CM; Haricharan S; Ellis MJ Cell Rep; 2018 Aug; 24(6):1434-1444.e7. PubMed ID: 30089255 [TBL] [Abstract][Full Text] [Related]
14. Application of next generation sequencing to human gene fusion detection: computational tools, features and perspectives. Wang Q; Xia J; Jia P; Pao W; Zhao Z Brief Bioinform; 2013 Jul; 14(4):506-19. PubMed ID: 22877769 [TBL] [Abstract][Full Text] [Related]
15. Functional linkage of gene fusions to cancer cell fitness assessed by pharmacological and CRISPR-Cas9 screening. Picco G; Chen ED; Alonso LG; Behan FM; Gonçalves E; Bignell G; Matchan A; Fu B; Banerjee R; Anderson E; Butler A; Benes CH; McDermott U; Dow D; Iorio F; Stronach E; Yang F; Yusa K; Saez-Rodriguez J; Garnett MJ Nat Commun; 2019 May; 10(1):2198. PubMed ID: 31097696 [TBL] [Abstract][Full Text] [Related]
16. FuGePrior: A novel gene fusion prioritization algorithm based on accurate fusion structure analysis in cancer RNA-seq samples. Paciello G; Ficarra E BMC Bioinformatics; 2017 Jan; 18(1):58. PubMed ID: 28114882 [TBL] [Abstract][Full Text] [Related]
18. Landscape of gene fusions in epithelial cancers: seq and ye shall find. Kumar-Sinha C; Kalyana-Sundaram S; Chinnaiyan AM Genome Med; 2015 Dec; 7():129. PubMed ID: 26684754 [TBL] [Abstract][Full Text] [Related]
19. What to expect from high throughput genomics in metastatic breast cancers? Onesti CE; Vicier C; André F Breast; 2015 Nov; 24 Suppl 2():S19-22. PubMed ID: 26238439 [TBL] [Abstract][Full Text] [Related]
20. Gene fusions in tumourigenesis with particular reference to ovarian cancer. Zhou Y; El-Bahrawy M J Med Genet; 2021 Dec; 58(12):789-795. PubMed ID: 34462289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]